Dr Elander joined The Clatterbridge Cancer Centre in 2022, specialising in hepatobiliary (HPB) cancers. He previously worked at Linköping University Hospital in Sweden, where he was chief physician in the department of oncology and head of the division for gastrointestinal, urological and dermatological medical oncology.
Dr Elander has a doctorate on genetic variations in colorectal cancer and subsequently completed post-doctorate research at the University of Liverpool in 2014-15. He established a research team at Linköping University and has published extensively in scientific peer-reviewed medical journals, on subjects including real world evidence on palliative chemotherapy in advanced HPB cancers and use of prognostic biomarkers.